JPRN-UMIN000009362已完成1 期
Phase I trial of combined chemotherapy of bevacizumab, panitumumab and irinotecan as 3rd-line chemotherapy in chmotherapy-refractory metastatic colorectal cancer. - Phase I trial of combined chemotherapy of bevacizumab, panitumumab and irinotecan as 3rd-line chemotherapy in chmotherapy-refractory metastatic colorectal cancer.
ational Cancer Center Hospital, Tokyo, Japan.0 个研究点目标入组 12 人开始时间: 2012年11月26日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Double advenced cancer 2) Past history of severe allergy of drugs 3) Active infection 4) Severe complication such as paresis of intestine, ileus, intestinal pneumonia, uncontrollable DM, cardiac disease, uncontrolled hypertension, thrombosis, renal failure, liver failure 5) Previous use of anti-EGFR antibodies 6) Uncontorollable pleural effusion and acites 7) Asymptomatic brain metastasis 8) Active bleeding of intestine 9) Uncontrollable diarrhea 10) Female with pregnancy 11) Inappropriate patients for clinical trial that are judged by doctors
研究者
相似试验
招募中
1 期
Phase I/II trial of combination chemotherapy using TS-1, CPT-11 and cetuximab with radiation in locally advanced rectal cancerRectal cancerJPRN-UMIN000002602Yokohama City University Graduate School of Medicine35
招募中
1 期
Phase I/II trial of combined chemotherapy of Nab-paclitaxel, S-1, and Oxaliplatin for gastric cancer patients with peritoneal metastasis (NSOX study)gastric cancer with peritoneal metastasisJPRN-UMIN000030909Wakayama Medical University, School of Medicine35
已完成
1 期
Phase I trial of Bevacizumab and S-1 chemotherapy for patients with previously treated advanced non-small cell lung cancerPreviously treated non-small cell lung cancerJPRN-UMIN000008613Thoracic Medical Oncology Cancer Institute Hospital of Japanese Foundation for Cancer Research15
已完成
不适用
Phase II trial as new chemotherapy regimen for bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancer.unresectable colorectal cancerJPRN-UMIN000010160Tsukasa Hotta27
已完成
1 期
Phase I study of combination chemotherapy with nab-paclitaxel and Nedaplatin as first-line treatment in patients with advanced squamous cell lung cancer.Squamous cell lung cancerJPRN-UMIN000010963Kitasato University School of Medicine Department of Respiratory Medicine16